HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY: ifrs:BasicEarningsLossPerShare
| Value | {"amount": 1.62} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | current |
| Entity | HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-23T22:45:21.755947+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/e4433162-bbee-4a1c-9729-f81deaaca701
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:549300BNS685UXH4JI75:2025-12-31Retrieved: 2026-08-23T22:45:21.755947+02:00
Raw response sha256:
c9b90e219264876c07ff9e67a0a5f951…Cite as: FACTANKER, https://factanker.com/fact/e4433162-bbee-4a1c-9729-f81deaaca701
History
- no predecessors — first report